GlucoMe, a comprehensive, digital diabetes care platform that intends to streamlines the disease management process for patients, medical teams and healthcare providers, announced yesterday that it has collaborated with Switzerland-based Roche as a new partner due to its involvement in the current Startup Creasphere Batch 2 Program.
Set-up by Roche and Plug and Play to accelerate digital healthcare Startup Creasphere is the first digital health innovation hub in Europe. GlucoMe was chosen to collaborate with Roche from one of 11 companies that are participating in the global initiative, following a screening process of more than 200 health-focused start-up companies.
GlucoMe's CEO, Yiftah Ben-Aharon, said, 'We are excited to partner with Roche and Plug & Play. From some very tough competition involving world-class promising digital health start-ups, the new Roche partnership will help GlucoMe rapidly advance our digital diabetes platform to set a new standard in diabetes care delivery.'
Hanmi Pharm enters exclusive licensing deal with Genentech for obesity therapy HM17321
Annexin Pharmaceuticals receives proposed INN vanexin for ANXV
Aqua Medical treats second type 2 diabetes patient in IDE trial of investigational PIMA procedure
ImmuPharma selects Kymos Group as bioanalytical partner for Kapiglucagon
Biocon launches Yesafili biosimilar in US ophthalmology market
Stevanato Group expands European adoption of Alina pen injector platform
Ascletis to discuss ASC36_35 FDC preclinical weight loss data at EASD annual meeting
Arch Biopartners engages private lab to advance IL-32 chronic kidney disease programme